Citations (139)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Nancy Tomes. (2023) Re-imagining the virus. Interdisciplinary Science Reviews 48:2, pages 235-249.
Read now
Read now
Vivek Chavda, Rajashri Bezbaruah, Tutumoni Kalita, Anupam Sarma, Juti Rani Devi, Ratnali Bania & Vasso Apostolopoulos. (2022) Variant influenza: connecting the missing dots. Expert Review of Anti-infective Therapy 20:12, pages 1567-1585.
Read now
Read now
Yu Bai, Qian Wang, Mingchen Liu, Lianlian Bian, Jianyang Liu, Fan Gao, Qunying Mao, Zhongfang Wang, Xing Wu, Miao Xu & Zhenglun Liang. (2022) The next major emergent infectious disease: reflections on vaccine emergency development strategies. Expert Review of Vaccines 21:4, pages 471-481.
Read now
Read now
Ruiqi Zhang & Ivan Fan-Ngai Hung. (2021) Approaches in broadening the neutralizing antibody response of the influenza vaccine. Expert Review of Vaccines 20:12, pages 1539-1547.
Read now
Read now
Yan-Yang Tao, Jing-Xin Li, Yue-Mei Hu, Yuan-Sheng Hu, Gang Zeng & Feng-Cai Zhu. (2021) Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis. Expert Review of Vaccines 20:1, pages 1-11.
Read now
Read now
Timo Vesikari, Miia Virta, Seppo Heinonen, Cécile Eymin, Nathalie Lavis, Anne Laure Chabanon & Viviane Gresset-Bourgeois. (2020) Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial. Human Vaccines & Immunotherapeutics 16:3, pages 623-629.
Read now
Read now
Asim Biswas, Alok K. Chakrabarti & Shanta Dutta. (2020) Current challenges: from the path of “original antigenic sin” towards the development of universal flu vaccines. International Reviews of Immunology 39:1, pages 21-36.
Read now
Read now
Ilaria Loperto, Andrea Simonetti, Antonio Nardone & Maria Triassi. (2019) Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence. Human Vaccines & Immunotherapeutics 15:5, pages 1035-1047.
Read now
Read now
Patricia R. Blank, Gerrit Adrianus van Essen, Raúl Ortiz de Lejarazu, Jan Kyncl, Aneta Nitsch-Osuch, Ernest Piotr Kuchar, Oana Falup-Pecurariu, Helena C. Maltezou, Dace Zavadska, Zuzana Kristufkova & George Kassianos. (2018) Impact of European vaccination policies on seasonal influenza vaccination coverage rates: An update seven years later. Human Vaccines & Immunotherapeutics 14:11, pages 2706-2714.
Read now
Read now
Claudia Maria Trombetta, Elena Gianchecchi & Emanuele Montomoli. (2018) Influenza vaccines: Evaluation of the safety profile. Human Vaccines & Immunotherapeutics 14:3, pages 657-670.
Read now
Read now
Won Suk Choi, Ji Yun Noh, Jacob Lee, Jun Yong Choi, Jin-Soo Lee, Moo Soo Kim, Hee Soo Kim, Joon Bang, Nathalie Lavis & Woo Joo Kim. (2018) Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18–60 years of age in the Republic of Korea. Human Vaccines & Immunotherapeutics 14:3, pages 587-592.
Read now
Read now
Viviane Gresset-Bourgeois, Phillip S. Leventhal, Stéphanie Pepin, Rosalind Hollingsworth, Marie-Pierre Kazek-Duret, Iris De Bruijn & Sandrine I. Samson. (2018) Quadrivalent inactivated influenza vaccine (VaxigripTetra™). Expert Review of Vaccines 17:1, pages 1-11.
Read now
Read now
Riju Ray, Gaël Dos Santos, Philip O. Buck, Carine Claeys, Gonçalo Matias, Bruce L. Innis & Rafik Bekkat-Berkani. (2017) A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control. Human Vaccines & Immunotherapeutics 13:7, pages 1640-1652.
Read now
Read now
Margaret Haugh, Viviane Gresset-Bourgeois, Bérengère Macabeo, Anne Woods & Sandrine I. Samson. (2017) A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries. Expert Review of Vaccines 16:6, pages 545-564.
Read now
Read now
Pedro L. Moro, Rongxia Li, Penina Haber, Eric Weintraub & Maria Cano. (2016) Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention. Expert Opinion on Drug Safety 15:9, pages 1175-1183.
Read now
Read now
Dorothy Lall, E. Cason, F. J. Pasquel, M. K. Ali & K. M. V. Narayan. (2016) Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low- and Middle-Income Countries. COPD: Journal of Chronic Obstructive Pulmonary Disease 13:1, pages 93-99.
Read now
Read now
Luzhao Feng, Peng Yang, Tao Zhang, Juan Yang, Chuanxi Fu, Ying Qin, Yi Zhang, Chunna Ma, Zhaoqiu Liu, Quanyi Wang, Genming Zhao & Hongjie Yu. (2015) Technical guidelines for the application of seasonal influenza vaccine in China (2014–2015). Human Vaccines & Immunotherapeutics 11:8, pages 2077-2101.
Read now
Read now
Guangyu Zhao, Yu Miao, Yan Guo, Hongjie Qiu, Shihui Sun, Zhihua Kou, Hong Yu, Junfeng Li, Yue Chen, Shibo Jiang, Lanying Du & Yusen Zhou. (2014) Development of a heat-stable and orally delivered recombinant M2e-expressing B. subtilis spore-based influenza vaccine. Human Vaccines & Immunotherapeutics 10:12, pages 3649-3658.
Read now
Read now
Laëtitia Minodier, Thierry Blanchon, Cecile Souty, Clement Turbelin, Frederic Leccia, Laurent Varesi & Alessandra Falchi. (2014) Influenza vaccine effectiveness: best practice and current limitations of the screening method and their implications for the clinic. Expert Review of Vaccines 13:8, pages 1039-1048.
Read now
Read now
Articles from other publishers (120)
Aristitsa Mikhailovna Kostinova, Elena Alexandrovna Latysheva, Nelly Kimovna Akhmatova, Anna Egorovna Vlasenko, Svetlana Anatolyevna Skhodova, Ekaterina Alexandrovna Khromova, Andrey Viktorovich Linok, Arseniy Alexandrovich Poddubikov, Tatyana Vasilievna Latysheva & Mikhail Petrovich Kostinov. (2023) Expression of Toll-like Receptors on the Immune Cells in Patients with Common Variable Immune Deficiency after Different Schemes of Influenza Vaccination. Viruses 15:10, pages 2091.
Crossref
Crossref
M.J. Nasiri, D.R. Silva, F. Rommasi, M.M. Zahmatkesh, Z. Tajabadi, F. Khelghati, T. Sarmastzadeh, R. Centis, L. D'Ambrosio, S. Bombarda, M.P. Dalcolmo, T. Galvão, F.C. de Queiroz Mello, M.F. Rabahi, E. Pontali, I. Solovic, M. Tadolini, L. Marconi, S. Tiberi, M. van den Boom, G. Sotgiu & G.B. Migliori. (2023) Vaccination in post-tuberculosis lung disease management: A review of the evidence. Pulmonology.
Crossref
Crossref
Rodrigo Luiz Carregaro, Alessandra N. C. P. Roscani, Augusto Cesar Sousa Raimundo, Larissa Ferreira, Tazio Vanni, Maria da Graça Salomão, Livia Fernandes Probst & Juliana Yukari K. Viscondi. (2023) Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews. BMC Infectious Diseases 23:1.
Crossref
Crossref
Abdul Rahman Ishak, Yu Chun Hsieh, Harshitha Srinivasan & Kay Choong See. (2023) Review of Vaccination Recommendations in Guidelines for Non-Communicable Diseases with Highest Global Disease Burden among Adults 75 Years Old and Above. Vaccines 11:6, pages 1076.
Crossref
Crossref
Clara R. Warmath, Ismael R. Ortega-Sanchez, Lindsey M. Duca, Rachael M. Porter, Molly G. Usher, Joseph S. Bresee, Kathryn E. Lafond & William W. Davis. (2023) Comparisons in the Health and Economic Assessments of Using Quadrivalent Versus Trivalent Influenza Vaccines: A Systematic Literature Review. Value in Health 26:5, pages 768-779.
Crossref
Crossref
Mallory L. Myers, John R. Gallagher, Alexander J. Kim, Walker H. Payne, Samantha Maldonado-Puga, Haralabos Assimakopoulos, Kevin W. Bock, Udana Torian, Ian N. Moore & Audray K. Harris. (2023) Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies. Nature Communications 14:1.
Crossref
Crossref
Michael Kozak & Jiafen Hu. (2023) The Integrated Consideration of Vaccine Platforms, Adjuvants, and Delivery Routes for Successful Vaccine Development. Vaccines 11:3, pages 695.
Crossref
Crossref
Shahla Shahsavandi & Amir Ali Hariri. (2023) SARS-CoV-2 Variant-Specific mRNA Vaccine: Pros and Cons. Viral Immunology.
Crossref
Crossref
Peter J. Slavish, Maxime G. Cuypers, Mary Ashley Rimmer, Alireza Abdolvahabi, Trushar Jeevan, Gyanendra Kumar, Jamie A. Jarusiewicz, Sivaraja Vaithiyalingam, Jeremy C. Jones, John J. Bowling, Jeanine E. Price, Rebecca M. DuBois, Jaeki Min, Richard J. Webby, Zoran Rankovic & Stephen W. White. (2023) Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potential. European Journal of Medicinal Chemistry 247, pages 115035.
Crossref
Crossref
Bernhard Gill, Theresa Kehler & Michael Schneider. 2023. Handbuch Umweltsoziologie. Handbuch Umweltsoziologie
1
14
.
Claudia Ferreira, Marie-Françoise J. Doursout & Joselito S. BalingitClaudia Ferreira, Marie-Françoise J. Doursout & Joselito S. Balingit. 2023. 2000 Years of Pandemics. 2000 Years of Pandemics
107
141
.
Sonia Jangra, Gabriel Laghlali, Angela Choi, Raveen Rathnasinghe, Yong Chen, Soner Yildiz, Lynda Coughlan, Adolfo García-Sastre, Bruno G. De Geest & Michael Schotsaert. (2022) RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine. Frontiers in Immunology 13.
Crossref
Crossref
Walid F. Elkhatib, Shereen S. Abdelkareem, Wafaa S. Khalaf, Mona I. Shahin, Dounia Elfadil, Alaa Alhazmi, Ahmed I. El-Batal & Gharieb S. El-Sayyad. (2022) Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting. Virology Journal 19:1.
Crossref
Crossref
Vladislav Deigin, Dmitry Koroev & Olga Volpina. (2022) Peptide ILE-GLU-TRP (Stemokin) Potential Adjuvant Stimulating a Balanced Immune Response. International Journal of Peptide Research and Therapeutics 28:6.
Crossref
Crossref
Florian Bonnet, Josselin Thuilliez & Hippolyte d'Albis. (2022) Influenza mortality in French regions after the Hong Kong flu pandemic. Demographic Research 47, pages 545-576.
Crossref
Crossref
Pierre A. Morgon. 2022. Principles of Biomedical Sciences and Industry. Principles of Biomedical Sciences and Industry
377
396
.
Dana M. Gates, Steven A. Cohen, Kelly Orr & Aisling R. Caffrey. (2022) Pediatric influenza vaccination rates lower than previous estimates in the United States. Vaccine 40:44, pages 6337-6343.
Crossref
Crossref
Mallory L. Myers, John R. Gallagher, De’Marcus D. Woolfork, Regan K. Stradtmann-Carvalho, Samantha Maldonado-Puga, Kevin W. Bock, Seyhan Boyoglu-Barnum, Hubza Syeda, Adrian Creanga, Derron A. Alves, Masaru Kanekiyo & Audray K. Harris. (2022) Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus. Frontiers in Immunology 13.
Crossref
Crossref
Zichun Wei, Jiarui He, Conghui Wang, Jiaqi Bao, Taiyang Leng & Fei Chen. (2022) The importance of booster vaccination in the context of Omicron wave. Frontiers in Immunology 13.
Crossref
Crossref
Yongbo Qiao, Shenghui Jin, Jiaojiao Nie, Yaotian Chang, Bo Wang, Shanshan Guan, Qinghan Li, Yuhua Shi, Wei Kong & Yaming Shan. (2022) Hemagglutinin-based DNA vaccines containing trimeric self-assembling nanoparticles confer protection against influenza. Journal of Leukocyte Biology 112:3, pages 547-556.
Crossref
Crossref
Jaekeun Park, Sharon L. Fong Legaspi, Louis M. SchwartzmanSebastian M. GygliZhong-Mei Sheng, Ashley D. Freeman, Lex M. Matthews, Yongli XiaoMitchell D. Ramuta, Natalia A. BatchenkovaLi Qi, Luz Angela Rosas, Stephanie L. Williams, Kelsey Scherler, Monica GouzoulisIan BellayrDavid M. Morens, Kathie-Anne Walters, Matthew J. Memoli, John C. Kash & Jeffery K. Taubenberger. (2022) An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets. Science Translational Medicine 14:653.
Crossref
Crossref
Irina Kiseleva. (2022) Current Opinion in LAIV: A Matter of Parent Virus Choice. International Journal of Molecular Sciences 23:12, pages 6815.
Crossref
Crossref
Rajamanonmani Ravikumar, Janlin Chan & Mookkan Prabakaran. (2022) Vaccines against Major Poultry Viral Diseases: Strategies to Improve the Breadth and Protective Efficacy. Viruses 14:6, pages 1195.
Crossref
Crossref
Mark B. Carascal, Rance Derrick N. Pavon & Windell L. Rivera. (2022) Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response. Frontiers in Immunology 13.
Crossref
Crossref
Mohammadreza Baqerkhani, Ali Soleimanzadeh, Hadi E.G. Ghaleh & Mahdieh Farzanehpour. (2022) Futurology and monitoring in the field of virology to deal with emerging diseases. Romanian Journal of Military Medicine 125:2, pages 253-263.
Crossref
Crossref
Samantha J. Shepherd. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
393
406
.
Yun‐Hee Kim, Kee‐Jong Hong, Hun Kim & Jae‐Hwan Nam. (2021) Influenza vaccines: Past, present, and future. Reviews in Medical Virology 32:1.
Crossref
Crossref
Janna R. Shapiro, Huifen Li, Rosemary Morgan, Yiyin Chen, Helen Kuo, Xiaoxuan Ning, Patrick Shea, Cunjin Wu, Katherine Merport, Rayna Saldanha, Suifeng Liu, Engle Abrams, Yan Chen, Denise C. Kelly, Eileen Sheridan-Malone, Lan Wang, Scott L. Zeger, Sabra L. Klein & Sean X. Leng. (2021) Sex-specific effects of aging on humoral immune responses to repeated influenza vaccination in older adults. npj Vaccines 6:1.
Crossref
Crossref
Vili Lampinen, Suvi Heinimäki, Olli H. Laitinen, Marko Pesu, Minna M. Hankaniemi, Vesna Blazevic & Vesa P. Hytönen. (2021) Modular vaccine platform based on the norovirus-like particle. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Juan Miguel Pascale, Danilo Franco, Raghavendra Devadiga, Rodrigo DeAntonio, Elidia Lourdes Dominguez-Salazar, Gael dos Santos & Patricia Juliao. (2021) Burden of Seasonal Influenza A and B in Panama from 2011 to 2017: An Observational Retrospective Database Study. Infectious Diseases and Therapy 10:4, pages 2465-2478.
Crossref
Crossref
Sara Belazi, Sonja J Olsen, Caroline Brown, Helen K Green, Piers Mook, Jonathan Nguyen-Van-Tam, Pasi Penttinen & Louise Lansbury. (2021) Spotlight influenza: Laboratory-confirmed seasonal influenza in people with acute respiratory illness: a literature review and meta-analysis, WHO European Region, 2004 to 2017. Eurosurveillance 26:39.
Crossref
Crossref
Tanja Becker, Husni Elbahesh, Leslie A Reperant, Guus F Rimmelzwaan & Albert D M E Osterhaus. (2021) Influenza Vaccines: Successes and Continuing Challenges. The Journal of Infectious Diseases 224:Supplement_4, pages S405-S419.
Crossref
Crossref
Anita Guerrini. (2021) Animals, vaccines, and COVID-19. Endeavour 45:3, pages 100779.
Crossref
Crossref
Ericka Kirkpatrick Roubidoux & Stacey Schultz-Cherry. (2021) Animal Models Utilized for the Development of Influenza Virus Vaccines. Vaccines 9:7, pages 787.
Crossref
Crossref
Abram L. Wagner, Lionel Gresh, Nery Sanchez, Guillermina Kuan, John Kubale, Roger Lopez, Sergio Ojeda, Eduardo Azziz-Baumgartner, Angel Balmaseda & Aubree Gordon. (2021) Influenza Illness and Partial Vaccination in the First Two Years of Life. Vaccines 9:6, pages 676.
Crossref
Crossref
Kobporn Boonnak, Chayasin Mansanguan, Dennis Schuerch, Usa Boonyuen, Hatairat Lerdsamran, Kultida Jiamsomboon, Fanny Sae Wang, Arun Huntrup, Jarunee Prasertsopon, Nathamon Kosoltanapiwat & Pilaipan Puthavathana. (2021) Molecular Characterization of Seasonal Influenza A and B from Hospitalized Patients in Thailand in 2018–2019. Viruses 13:6, pages 977.
Crossref
Crossref
Kotaro Mori, Ryosuke L. Ohniwa, Naoki Takizawa, Tadasuke Naito & Mineki Saito. (2021) Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain Using an Engineered High-Fidelity Viral Polymerase. Journal of Virology 95:12.
Crossref
Crossref
Sylwia Kałucka & Izabela Grzegorczyk-Karolak. (2021) Barriers Associated with the Uptake Ratio of Seasonal Flu Vaccine and Ways to Improve Influenza Vaccination Coverage among Young Health Care Workers in Poland. Vaccines 9:5, pages 530.
Crossref
Crossref
Shani Witman Tsur, Eli Adrian Zaher, Meydan Tsur, Karolina Kania & Alicja Kalinowska-Łyszczarz. (2021) Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?. International Journal of Molecular Sciences 22:8, pages 3859.
Crossref
Crossref
Mia Diaco, Lee-Jah Chang, Bruce Seet, Corey A Robertson, Ayman Chit, Monica Mercer, David P Greenberg, Rosalind Hollingsworth & Sandrine I. Samson. (2021) Introductory paper: High-dose influenza vaccine. Vaccine 39, pages A1-A5.
Crossref
Crossref
Miguel Betancourt-Cravioto, Jorge Abelardo Falcón-Lezama, Rodrigo Saucedo-Martínez, Myrna María Alfaro-Cortés & Roberto Tapia-Conyer. (2021) Public Health and Economic Benefits of Influenza Vaccination of the Population Aged 50 to 59 Years without Risk Factors for Influenza Complications in Mexico: A Cross-Sectional Epidemiological Study. Vaccines 9:3, pages 188.
Crossref
Crossref
Emin Umit Bagriacik. 2021. Nanotechnology Applications in Health and Environmental Sciences. Nanotechnology Applications in Health and Environmental Sciences
291
298
.
Till Koch, Anahita Fathi & Marylyn M. Addo. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19
549
573
.
Lauren Fine & Nofar Kimchi. 2021. Primary and Secondary Immunodeficiency. Primary and Secondary Immunodeficiency
397
410
.
Jorge Abelardo Falcón-Lezama, Rodrigo Saucedo-Martínez, Miguel Betancourt-Cravioto, Myrna María Alfaro-Cortes, Roberto Isaac Bahena-González & Roberto Tapia-Conyer. (2020) Influenza in the school-aged population in Mexico: burden of disease and cost-effectiveness of vaccination in children. BMC Infectious Diseases 20:1.
Crossref
Crossref
Brayan Viana Ribeiro, Taís Aparecida Reis Cordeiro, Guilherme Ramos Oliveira e Freitas, Lucas Franco Ferreira & Diego Leoni Franco. (2020) Biosensors for the detection of respiratory viruses: A review. Talanta Open 2, pages 100007.
Crossref
Crossref
Steven Rockman, Karen L. Laurie, Simone Parkes, Adam Wheatley & Ian G. Barr. (2020) New Technologies for Influenza Vaccines. Microorganisms 8:11, pages 1745.
Crossref
Crossref
Sigrid GoumaElizabeth M. AndersonScott E. Hensley. (2020) Challenges of Making Effective Influenza Vaccines. Annual Review of Virology 7:1, pages 495-512.
Crossref
Crossref
Laurence S. Sperling, Michelle A. Albert & Ram Koppaka. (2020) Disparities in Influenza Vaccination—Opportunity to Extend Cardiovascular Prevention to Millions of Hearts. JAMA Cardiology.
Crossref
Crossref
Aristitsa Mikhailovna Kostinova, Nelli Kimovna Akhmatova, Elena Alexandrovna Latysheva, Yulia Alexeevna Dagil, Svetlana Valentinovna Klimova, Anna Egorovna Vlasenko, Ekaterina Alexandrovna Khromova, Tatyana Vasilievna Latysheva & Mikhail Petrovich Kostinov. (2020) Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency. Frontiers in Immunology 11.
Crossref
Crossref
Jeffrey Baker, Stanley L. Block, Balpreet Matharu, Laura Burleigh Macutkiewicz, Steffen Wildum, Sophie Dimonaco, Neil Collinson, Barry Clinch & Pedro A. Piedra. (2020) Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children. Pediatric Infectious Disease Journal 39:8, pages 700-705.
Crossref
Crossref
Yao Yu, Hai-Juan Qin, Xiao-Xiao Shi, Jia-Qi Song, Jia-Ping Zhou, Peng Yu, Zhen-Chuan Fan, Ming Zhong & Yang Yang. (2020) Thiosialoside-decorated polymers use a two-step mechanism to inhibit both early and late stages of influenza virus infection. European Journal of Medicinal Chemistry 199, pages 112357.
Crossref
Crossref
John S. Tsang, Carlota Dobaño, Pierre VanDamme, Gemma Moncunill, Arnaud Marchant, Rym Ben Othman, Manish Sadarangani, Wayne C. Koff & Tobias R. Kollmann. (2020) Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?. Trends in Immunology 41:6, pages 457-465.
Crossref
Crossref
Irina Kiseleva, Andrey Rekstin, Mohammad Al Farroukh, Ekaterina Bazhenova, Anastasia Katelnikova, Ludmila Puchkova & Larisa Rudenko. (2020) Non-Mouse-Adapted H1N1pdm09 Virus as a Model for Influenza Research. Viruses 12:6, pages 590.
Crossref
Crossref
Pascal Crépey, Esther Redondo, Javier Díez-Domingo, Raúl Ortiz de Lejarazu, Federico Martinón-Torres, Ángel Gil de Miguel, Juan Luis López-Belmonte, Fabián P. Alvarez, Hélène Bricout & Míriam Solozabal. (2020) From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain. PLOS ONE 15:5, pages e0233526.
Crossref
Crossref
Rodrigo B. Abreu, Emily F. Clutter, Sara Attari, Giuseppe A. Sautto & Ted M. Ross. (2020) IgA Responses Following Recurrent Influenza Virus Vaccination. Frontiers in Immunology 11.
Crossref
Crossref
Masato Kubo & Kosuke Miyauchi. (2020) Breadth of Antibody Responses during Influenza Virus Infection and Vaccination. Trends in Immunology 41:5, pages 394-405.
Crossref
Crossref
Anna Kirsteina, Inara Akopjana, Janis Bogans, Ilva Lieknina, Juris Jansons, Dace Skrastina, Tatjana Kazaka, Kaspars Tars, Irina Isakova-Sivak, Daria Mezhenskaya, Tatiana Kotomina, Victoria Matyushenko, Larisa Rudenko & Andris Kazaks. (2020) Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens. Vaccines 8:2, pages 197.
Crossref
Crossref
José Antonio Navarro Alonso. (2020) La gripe: 76 años de vacuna antigripal… ¡y de la hemaglutinina!. Revista Madrileña de Salud Pública 3:11, pages 1-8.
Crossref
Crossref
Rodrigo B. Abreu, Greg A. Kirchenbaum, Emily F. Clutter, Giuseppe A. Sautto & Ted M. Ross. (2020) Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination. JCI Insight 5:1.
Crossref
Crossref
Guzin Zeren Ozturk, Seda Ozmen, Memet Taskin Egici & Ekmel Burak Ozsenel. (2020) Results of Influenza Vaccination: Short Follow-Up Study of a Turkish Population. Revista da Sociedade Brasileira de Medicina Tropical 53.
Crossref
Crossref
Wonil Chae, Paul Kim, Hanna Kim, Yu Cheol Cheong, Young-Seok Kim, Sang Moo Kang & Baik L. Seong. (2019) Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies. Scientific Reports 9:1.
Crossref
Crossref
Guozhong He, Pengfei Yang, Qingli Yan & Chenglong Xiong. (2019) Debate on the compositions of influenza B in northern hemisphere seasonal influenza vaccines. Antimicrobial Resistance & Infection Control 8:1.
Crossref
Crossref
Ancelmo Rabelo de Souza, Marriam Yamin, Danielle Gava, Janice Reis Ciacci Zanella, Maria Sílvia Viccari Gatti, Carlos Francisco Sampaio Bonafe & Daniel Ferreira de Lima Neto. (2019) Porcine parvovirus VP1/VP2 on a time series epitope mapping: exploring the effects of high hydrostatic pressure on the immune recognition of antigens. Virology Journal 16:1.
Crossref
Crossref
Joan Puig-Barberà, Ainara Mira-Iglesias, Elena Burtseva, Benjamin J. Cowling, Unal Serhat, Guillermo Miguel Ruiz-Palacios, Odile Launay, Jan Kyncl, Parvaiz Koul, Marilda M. Siqueira & Anna Sominina. (2019) Influenza epidemiology and influenza vaccine effectiveness during the 2015–2016 season: results from the Global Influenza Hospital Surveillance Network. BMC Infectious Diseases 19:1.
Crossref
Crossref
Martina Havlickova, Sophie Druelles, Helena Jirincova, Radomira Limberkova, Alexander Nagy, Anvar Rasuli & Jan Kyncl. (2019) Circulation of influenza A and B in the Czech Republic from 2000-2001 to 2015-2016. BMC Infectious Diseases 19:1.
Crossref
Crossref
Yo Han Jang & Baik Lin Seong. (2019) The Quest for a Truly Universal Influenza Vaccine. Frontiers in Cellular and Infection Microbiology 9.
Crossref
Crossref
Maarten van Wijhe, Pieter T. de Boer, Herman J. de Jong, Hans van Vliet, Jacco Wallinga & Maarten J. Postma. (2019) Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis. Vaccine 37:38, pages 5698-5707.
Crossref
Crossref
Rakhee Palekar, Angel Rodriguez, Cinthia Avila, Gisela Barrera, Miriam Barrera, Hebleen Brenes, Alfedo Bruno, Nathalie El Omeiri, Rodrigo Fasce, Walquiria Ferreira de Almeida, Danilo Franco, Maribel Huaringa, Jenny Lara, Roxana Loayza, Irma Lopez-Martinez, Terezinha Maria de Paiva, Jose Medina, Jenny Ojeda, Alba Maria Ropero, Viviana Sotomayor, Cynthia Vazquez & Marta Von Horoch. (2019) Patterns of influenza B circulation in Latin America and the Caribbean, 2010–2017. PLOS ONE 14:8, pages e0219595.
Crossref
Crossref
Kuo-Hsuan Chang, Rong-Kuo Lyu, Wan-Ting Lin, Yu-Tung Huang, Huang-Shen Lin & Shang-Hung Chang. (2019) Gulllain-Barre Syndrome After Trivalent Influenza Vaccination in Adults. Frontiers in Neurology 10.
Crossref
Crossref
Tanhai G Borkar & Vidul Goenka. (2019) Techniques Employed in Production of Traditional Vaccines Commonly Used by Military Forces: A Review. Journal of Archives in Military Medicine 7:1-2.
Crossref
Crossref
Xinci Xie, Chen Zhao, Qian He, Tianyi Qiu, Songhua Yuan, Longfei Ding, Lu Liu, Lang Jiang, Jing Wang, Linxia Zhang, Chao Zhang, Xiang Wang, Dongming Zhou, Xiaoyan Zhang & Jianqing Xu. (2019) Influenza Vaccine With Consensus Internal Antigens as Immunogens Provides Cross-Group Protection Against Influenza A Viruses. Frontiers in Microbiology 10.
Crossref
Crossref
Sean A. Nelson & Andrea J. Sant. (2019) Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus. Frontiers in Immunology 10.
Crossref
Crossref
Adolfo García-Sastre. (2019) Snatch-and-Grab Inhibitors to Fight the Flu. Cell 177:6, pages 1367.
Crossref
Crossref
Amy Caryn Sherman, Aneesh Mehta, Neal W. Dickert, Evan J. Anderson & Nadine Rouphael. (2019) The Future of Flu: A Review of the Human Challenge Model and Systems Biology for Advancement of Influenza Vaccinology. Frontiers in Cellular and Infection Microbiology 9.
Crossref
Crossref
Magen Francis, Morgan King & Alyson Kelvin. (2019) Back to the Future for Influenza Preimmunity—Looking Back at Influenza Virus History to Infer the Outcome of Future Infections. Viruses 11:2, pages 122.
Crossref
Crossref
Sarah Kabbani & Mark J. Mulligan. 2019. Clinical Immunology. Clinical Immunology
1211
1226.e1
.
Biao Wang & Mark Loeb. 2019. Vaccinations. Vaccinations
89
103
.
Erik A. Karlsson, J. Justin Milner, William D. Green, Jennifer Rebeles, Stacey Schultz-Cherry & Melinda A. Beck. 2019. Mechanisms and Manifestations of Obesity in Lung Disease. Mechanisms and Manifestations of Obesity in Lung Disease
227
259
.
Mohsen Keshavarz, Hamed Mirzaei, Maryam Salemi, Fatemeh Momeni, Mohammad Javad Mousavi, Mona Sadeghalvad, Yaser Arjeini, Farid Solaymani‐Mohammadi, Javid Sadri Nahand, Haideh Namdari, Talat Mokhtari‐Azad & Farhad Rezaei. (2018) Influenza vaccine: Where are we and where do we go?. Reviews in Medical Virology 29:1.
Crossref
Crossref
Ning Sun, Weiping Wang, Jie Wang, Xinyue Yao, Fangfang Chen, Xiaojun Li, Yi Yinglei & Bo Chen. (2018) Reverse transcription recombinase polymerase amplification with lateral flow dipsticks for detection of influenza A virus and subtyping of H1 and H3. Molecular and Cellular Probes 42, pages 25-31.
Crossref
Crossref
Elizabeth Q. Littauer & Ioanna Skountzou. (2018) Hormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy. Frontiers in Immunology 9.
Crossref
Crossref
Anne Mosnier, Odile Launay, Luc Martinez, Gaëtan Gavazzi, Laurence Josset, Pascal Crepey, Claude Hannoun, Catherine Weil-Olivier & Jacques Gaillat. (2018) Vaccin grippal quadrivalent : quels changements pour quels bénéfices ?. La Presse Médicale 47:10, pages 842-853.
Crossref
Crossref
Clement Meseko, Binod Kumar & Melvin Sanicas. 2018. Influenza - Therapeutics and Challenges. Influenza - Therapeutics and Challenges.
José Antonio López Trigo, Rosa López Mongil, Alberto Mariano Lázaro, Gloria Mato Chaín, Norberto Moreno Villajos & Primitivo Ramos Cordero. (2018) Vacunación frente a la gripe estacional en las personas mayores. Evaluación de la vacuna tetravalente. Informe de posicionamiento. Revista Española de Geriatría y Gerontología 53, pages 185-202.
Crossref
Crossref
Nicole Bouvier. (2018) The Future of Influenza Vaccines: A Historical and Clinical Perspective. Vaccines 6:3, pages 58.
Crossref
Crossref
Fan Zhou, Mai-Chi Trieu, Richard Davies & Rebecca Jane Cox. (2018) Improving influenza vaccines: challenges to effective implementation. Current Opinion in Immunology 53, pages 88-95.
Crossref
Crossref
Raffael Nachbagauer & Peter Palese. (2018) Development of next generation hemagglutinin-based broadly protective influenza virus vaccines. Current Opinion in Immunology 53, pages 51-57.
Crossref
Crossref
Hillary L. Shane, Katie L. Reagin & Kimberly D. Klonowski. (2018) The Respiratory Environment Diverts the Development of Antiviral Memory CD8 T Cells. The Journal of Immunology 200:11, pages 3752-3761.
Crossref
Crossref
Michelle M. HughesNazia S. SaiyedTiffany S. Chen. (2018) Local-Level Adult Influenza and Pneumococcal Vaccination Disparities: Chicago, Illinois, 2015–2016. American Journal of Public Health 108:4, pages 517-523.
Crossref
Crossref
Emanuele Montomoli, Alessandro Torelli, Ilaria Manini & Elena Gianchecchi. (2018) Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults. Vaccines 6:1, pages 14.
Crossref
Crossref
Usman Sumo Frien. (2017) Changes in Germs: A Potential Preemptive Strike Against the Next Pandemic. Journal of Medical Sciences 18:1, pages 48-55.
Crossref
Crossref
Barry Lorbetskie, Nathalie Fortin, Laura Durno, Junzhi Wang, Changgui Li, Xuguang Li, Michel Girard & Simon Sauvé. (2017) Fast and highly selective determination of hemagglutinin content in quadrivalent influenza vaccine by reversed-phase high-performance liquid chromatography method. Journal of Chromatography A 1528, pages 18-24.
Crossref
Crossref
Peter H. Goff, Tomoko Hayashi, Wenqian He, Shiyin Yao, Howard B. Cottam, Gene S. Tan, Brian Crain, Florian Krammer, Karen Messer, Minya Pu, Dennis A. Carson, Peter Palese & Maripat Corr. (2017) Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice. Journal of Virology 91:19.
Crossref
Crossref
Jirapat Arunorat, Nataya Charoenvisal, Yonlayong Woonwong, Roongtham Kedkovid, Supattra Jittimanee, Panchan Sitthicharoenchai, Sawang Kesdangsakonwut, Pariwat Poolperm & Roongroje Thanawongnuwech. (2017) Protection of human influenza vaccines against a reassortant swine influenza virus of pandemic H1N1 origin using a pig model. Research in Veterinary Science 114, pages 6-11.
Crossref
Crossref
Wanitchaya Kittikraisak, Piyarat Suntarattiwong, Darunee Ditsungnoen, Sarah E. Pallas, Taiwo O. Abimbola, Chonticha Klungthong, Stefan Fernandez, Suchada Srisarang, Tawee Chotpitayasunondh, Fatimah S. Dawood, Sonja J. Olsen & Kim A. Lindblade. (2017) Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children ≤60 months of age. PLOS ONE 12:8, pages e0183391.
Crossref
Crossref
Wenhan Shao, Xinxin Li, Mohsan Goraya, Song Wang & Ji-Long Chen. (2017) Evolution of Influenza A Virus by Mutation and Re-Assortment. International Journal of Molecular Sciences 18:8, pages 1650.
Crossref
Crossref
Ham Ching LamXuan BiSrinand SreevatsanDaniel Boley. (2017) Evolution and Vaccination of Influenza Virus. Journal of Computational Biology 24:8, pages 787-798.
Crossref
Crossref
Jeremy C. Jones, Bindumadhav M. Marathe, Peter Vogel, Rodolfo Gasser, Isabel Najera & Elena A. Govorkova. (2017) The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses. Antimicrobial Agents and Chemotherapy 61:5.
Crossref
Crossref
Albert Vollaard, Imke Schreuder, Lizzy Slok-Raijmakers, Wim Opstelten, Guus Rimmelzwaan & Hans Gelderblom. (2017) Influenza vaccination in adult patients with solid tumours treated with chemotherapy. European Journal of Cancer 76, pages 134-143.
Crossref
Crossref
Chia-Yun Lo, Susan L. Strobl, Kimberly Dunham, Wei Wang, Lucy Stewart, Julia A. Misplon, Mayra Garcia, Jin Gao, Tatsuhiko Ozawa, Graeme E. Price, Jose Navidad, Steve Gradus, Sanjib Bhattacharyya, Cecile Viboud, Maryna C. Eichelberger, Carol D. Weiss, Jack Gorski & Suzanne L. Epstein. (2017) Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic. Open Forum Infectious Diseases 4:2.
Crossref
Crossref
Aye M. Moa, David J. Muscatello, Robin M. Turner & Chandini R. MacIntyre. (2017) Epidemiology of influenza B in Australia: 2001-2014 influenza seasons. Influenza and Other Respiratory Viruses 11:2, pages 102-109.
Crossref
Crossref
Brian J. Lenny, Stephanie Sonnberg, Angela F. Danner, Kimberly Friedman, Richard J. Webby, Robert G. Webster & Jeremy C. Jones. (2017) Evaluation of multivalent H2 influenza pandemic vaccines in mice. Vaccine 35:10, pages 1455-1463.
Crossref
Crossref
Barnaby Young, Xiahong Zhao, Alex R. Cook, Christopher M. Parry, Annelies Wilder-Smith & Mark Chen I-Cheng. (2017) Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis. Vaccine 35:2, pages 212-221.
Crossref
Crossref
Bin Zhou, Victoria A. Meliopoulos, Wei Wang, Xudong Lin, Karla M. Stucker, Rebecca A. Halpin, Timothy B. Stockwell, Stacey Schultz-Cherry & David E. Wentworth. (2016) Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus. Journal of Virology 90:19, pages 8454-8463.
Crossref
Crossref
Jeremy C. Jones, Bindumadhav M. Marathe, Christian Lerner, Lukas Kreis, Rodolfo Gasser, Philippe Noriel Q. Pascua, Isabel Najera & Elena A. Govorkova. (2016)
A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity
In Vitro
. Antimicrobial Agents and Chemotherapy 60:9, pages 5504-5514.
Crossref
Crossref
Aye M. Moa, Abrar A. Chughtai, David J. Muscatello, Robin M. Turner & C. Raina MacIntyre. (2016) Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials. Vaccine 34:35, pages 4092-4102.
Crossref
Crossref
Priyadharshini Devarajan, Bianca Bautista, Allen M. Vong, Karl Kai McKinstry, Tara M. Strutt & Susan L. Swain. (2016) New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for Influenza. Frontiers in Immunology 7.
Crossref
Crossref
Shin-ichi Tamura, Akira Ainai, Tadaki Suzuki, Takeshi Kurata & Hideki Hasegawa. (2016) Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?. Japanese Journal of Infectious Diseases 69:3, pages 165-179.
Crossref
Crossref
. 2016. Molecular Microbiology. Molecular Microbiology
306
335
.
Ali H. Ellebedy & Rafi Ahmed. 2016. The Vaccine Book. The Vaccine Book
283
310
.
Freek Cox, Matthijs Baart, Jeroen Huizingh, Jeroen Tolboom, Liesbeth Dekking, Jaap Goudsmit, Eirikur Saeland & Katarina Radošević. (2015) Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells. PLOS ONE 10:12, pages e0145243.
Crossref
Crossref
Anne Mosnier, Saverio Caini, Isabelle Daviaud, Jean-Louis Bensoussan, Françoise Stoll-Keller, Tan Tai Bui, Bruno Lina, Sylvie Van der Werf & Jean Marie Cohen. (2015) Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003–2013. BMC Infectious Diseases 15:1.
Crossref
Crossref
Vladimir Beljanski, Cindy Chiang, Greg A. Kirchenbaum, David Olagnier, Chalise E. Bloom, Terianne Wong, Elias K. Haddad, Lydie Trautmann, Ted M. Ross & John Hiscott. (2015) Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant. Journal of Virology 89:20, pages 10612-10624.
Crossref
Crossref
Freek Cox, Anna Roos, Nicole Hafkemeijer, Matthijs Baart, Jeroen Tolboom, Liesbeth Dekking, Koert Stittelaar, Jaap Goudsmit, Katarina Radošević & Eirikur Saeland. (2015) Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge. PLOS ONE 10:9, pages e0135723.
Crossref
Crossref
Pascal Crépey, Pieter T. de Boer, Maarten J. Postma & Richard Pitman. (2015) Retrospective public health impact of a quadrivalent influenza vaccine in the United States. Influenza and Other Respiratory Viruses 9:S1, pages 39-46.
Crossref
Crossref
Peter H. Goff, Tomoko Hayashi, Luis Martínez-Gil, Maripat Corr, Brian Crain, Shiyin Yao, Howard B. Cottam, Michael Chan, Irene Ramos, Dirk Eggink, Mitra Heshmati, Florian Krammer, Karen Messer, Minya Pu, Ana Fernandez-Sesma, Peter Palese & Dennis A. Carson. (2015) Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands as Influenza Virus Vaccine Adjuvants Induce Rapid, Sustained, and Broadly Protective Responses. Journal of Virology 89:6, pages 3221-3235.
Crossref
Crossref
Katherine Houser & Kanta Subbarao. (2015) Influenza Vaccines: Challenges and Solutions. Cell Host & Microbe 17:3, pages 295-300.
Crossref
Crossref
Giuseppe Del Giudice & Rino Rappuoli. 2015. Influenza Pathogenesis and Control - Volume II. Influenza Pathogenesis and Control - Volume II
151
180
.
Ji Yun NohWoo Joo Kim. (2013) Influenza Vaccines: Unmet Needs and Recent Developments. Infection & Chemotherapy 45:4, pages 375.
Crossref
Crossref